Manya Dhar-Mascareno

manya-mascareno

MedHexim1

2014-2015

MedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer.

Newsletter Signup

Corporate Supporters

Community Service Providers